Oder Investment Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Oder Investment Management, LLC
- $130 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,451Shares Held
86.9MCall Options Held
1.77MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA9.05MShares$5.95 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.55 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.18 Billion0.1% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.68 Billion0.15% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.52 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $70.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...